Stay updated on Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Sign up to get notified when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.

Latest updates to the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThere are no additions or deletions to report for this page based on the provided data.SummaryDifference0.2%

- Check18 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal HTML header, replacing the typical study details. The additions include the '403' label, a short DOCTYPE/HTML snippet, a 'Home' link, and a 'Revision: v3.7.0' note.SummaryDifference17%

- Check39 days agoChange DetectedThe site’s revision number was updated from v3.6.5 to v3.6.6, indicating a behind-the-scenes deployment.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, reflecting a minor update to the record in the page history.SummaryDifference0.0%

- Check67 days agoChange DetectedEnrollment status now indicates recruitment is closed with the added line 'No longer looking for participants'. Deletions remove older status descriptors to reflect the finalized recruitment status.SummaryDifference0.2%

- Check75 days agoChange DetectedThe page now shows revision tag v3.6.4, replacing the previous v3.6.3. This indicates a minor update to the page's version metadata.SummaryDifference0.0%

Stay in the know with updates to Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Enter your email address, and we'll notify you when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.